A new trading day began on Tuesday, with Corcept Therapeutics Inc (NASDAQ: CORT) stock price up 3.40% from the previous day of trading, before settling in for the closing price of $45.30. CORT’s price has ranged from $20.84 to $47.71 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 14.14% over the past five years. Meanwhile, its annual earnings per share averaged 19.28%. With a float of $89.95 million, this company’s outstanding shares have now reached $103.41 million.
Let’s look at the performance matrix of the company that is accounted for 352 employees. In terms of profitability, gross margin is 98.49%, operating margin of 22.46%, and the pretax margin is 26.3%.
Corcept Therapeutics Inc (CORT) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Corcept Therapeutics Inc is 13.91%, while institutional ownership is 83.54%. The most recent insider transaction that took place on Oct 01 ’24, was worth 462,800. In this transaction Chief Development Officer of this company sold 10,000 shares at a rate of $46.28, taking the stock ownership to the 5,796 shares. Before that another transaction happened on Oct 01 ’24, when Company’s Chief Business Officer sold 11,000 for $46.28, making the entire transaction worth $509,080. This insider now owns 22,772 shares in total.
Corcept Therapeutics Inc (CORT) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 19.28% per share during the next fiscal year.
Corcept Therapeutics Inc (NASDAQ: CORT) Trading Performance Indicators
Here are Corcept Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.59. Likewise, its price to free cash flow for the trailing twelve months is 39.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.13, a number that is poised to hit 0.28 in the next quarter and is forecasted to reach 1.84 in one year’s time.
Technical Analysis of Corcept Therapeutics Inc (CORT)
Corcept Therapeutics Inc (NASDAQ: CORT) saw its 5-day average volume 0.86 million, a negative change from its year-to-date volume of 1.18 million. As of the previous 9 days, the stock’s Stochastic %D was 51.63%. Additionally, its Average True Range was 1.78.
During the past 100 days, Corcept Therapeutics Inc’s (CORT) raw stochastic average was set at 95.74%, which indicates a significant increase from 83.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.83% in the past 14 days, which was lower than the 46.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $38.79, while its 200-day Moving Average is $29.88. Nevertheless, the first resistance level for the watch stands at $47.49 in the near term. At $48.14, the stock is likely to face the second major resistance level. The third major resistance level sits at $49.30. If the price goes on to break the first support level at $45.68, it is likely to go to the next support level at $44.52. Assuming the price breaks the second support level, the third support level stands at $43.87.
Corcept Therapeutics Inc (NASDAQ: CORT) Key Stats
With a market capitalization of 4.89 billion, the company has a total of 104,110K Shares Outstanding. Currently, annual sales are 482,380 K while annual income is 106,140 K. The company’s previous quarter sales were 163,800 K while its latest quarter income was 35,490 K.
